HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 39.250
  • -0.250-0.63%
Trading Nov 22 10:01 CST
10.98BMarket Cap-13487P/E (TTM)

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KEYMED BIO-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 544.918M--
--2024/FY-- / 140.560M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 544.918M--
--2024/FY-- / 140.560M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--

Unlock Free Earnings Estimates

KEYMED BIO-B Earnings Reports

  • KEYMED BIO-B: 2024 INTERIM REPORT

    Sep 23 21:01

  • KEYMED BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

    Aug 27 18:23

  • KEYMED BIO-B: DATE OF BOARD MEETING

    Aug 15 16:35

  • KEYMED BIO-B: 2023 ANNUAL REPORT

    Apr 24 16:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data